Shi Ning, Liu Shang-Long, Li Ya-Tong, You Lei, Dai Meng-Hua, Zhao Yu-Pei
Ann Surg Oncol. 2016 Feb;23(2):365-74. doi: 10.1245/s10434-015-4870-z.
Studies have been published comparing spleen-preserving distal pancreatectomy (SPDP) with distal pancreatectomy with splenectomy (DPS), but the results remain inconsistent. The aim of this study was to compare SPDP with DPS by conducting a systematic review and meta-analysis.
Literature searches of the Medline/PubMed, Embase, and Cochrane Library databases were performed to identify relevant studies published before April 30,2015. Perioperative outcomes of SPDP and DPS were evaluated. The meta-analysis was performed in random- or fixed-effects models, as appropriate. A subanalysis was conducted to compare the two techniques of splenic preservation: splenic vessel preservation (SVP) and Warshaw technique (WT).
Eighteen studies and 1156 patients were included in the comparison between SPDP and DPS. A total of 502 of these patients underwent SPDP and 654 underwent DPS. Meta-analysis showed the SPDP group had significantly fewer infectious complications (odds ratio [OR] 0.57, P = 0.006), less operative blood loss (P<0.0001), lower overall morbidity rate (OR 0.66, P = 0.002), and lower clinical pancreatic fistula rate (OR 0.42, P = 0.002) than the DPS group. Subanalysis indicated the SVP group had significantly lower rate of spleen infarction (OR 0.12, P<0.00001) and fewer secondary splenectomies (OR 0.13, P = 0.008) than the WT group.
SPDP was a safe procedure associated with better short-term outcomes than DPS. SVP could provide more sufficient blood perfusion for the conserved spleen than WT. However, the evidence is limited, and more randomized controlled trials are warranted.
已有研究发表,比较了保留脾脏的胰体尾切除术(SPDP)和联合脾切除术的胰体尾切除术(DPS),但结果仍不一致。本研究的目的是通过进行系统评价和荟萃分析来比较SPDP和DPS。
对Medline/PubMed、Embase和Cochrane图书馆数据库进行文献检索,以识别2015年4月30日前发表的相关研究。评估了SPDP和DPS的围手术期结果。根据情况,在随机或固定效应模型中进行荟萃分析。进行了一项亚分析,以比较两种脾脏保留技术:脾血管保留(SVP)和Warshaw技术(WT)。
18项研究和1156例患者纳入了SPDP和DPS的比较。其中共有502例患者接受了SPDP,654例接受了DPS。荟萃分析显示,与DPS组相比,SPDP组的感染并发症显著更少(优势比[OR]0.57,P = 0.006),术中失血更少(P<0.0001),总体发病率更低(OR 0.66,P = 0.002),临床胰瘘率更低(OR 0.42,P = 0.002)。亚分析表明,与WT组相比,SVP组的脾梗死率显著更低(OR 0.12,P<0.00001),二次脾切除术更少(OR 0.13,P = 0.008)。
SPDP是一种安全的手术,与DPS相比具有更好的短期结局。与WT相比,SVP可为保留的脾脏提供更充足的血液灌注。然而,证据有限,需要更多的随机对照试验。